About
Cellsbin develops technologies for ultrasensitive detection and profiling of rare therapeutic cells in human blood to advance precision diagnostics and therapies, particularly for monitoring disease and therapy response in conditions like multiple myeloma.
Explore Cellsbin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.